Development and Validation of Computer Spreadsheet Used to Calculate Dissolution Profiles without Media Replacement

Imad Osman Abu Reid

Abstract


Calculations carried out to generate dissolution profile data are complicated and subject to error to be performed manually, moreover and due to the repetitive nature of the dissolution testing experiments it is necessary to create a validated spreadsheet to replace and overcome the problems associated with manual calculations. A simple, user friendly spreadsheet was written to calculate dissolution profiles for a dissolution experiment where the volume of the dissolution medium for the vessel varies with time as the removed dissolution medium is not replaced with fresh one at each time point. The calculations of the spreadsheet were validated against manual calculations using a hand-held calculator; the results of the two methods were found to be comparable. The developed spreadsheet can be easily adapted for use in regulated environment after activating the security features embedded in Microsoft Excel software such as formula hiding, cell block and password protection.  


Keywords


Spreadsheet; Dissolution profiles calculation without media replacement

Full Text:

PDF

References


Guidance for Industry, Immediate Release Solid Dosage Forms, Scale-up and Post-Approval Changes: Chemistry, Manufacturing and Controls, In vitro Dissolution Testing, and In vivo Bioequivalence Documentation, CDER, Food and Drug Administration, USA; 1995.

Dissolution Testing of Solid Oral Products: Joint Report of the Section for Official Laboratories and Medicines Control Services and the Section of Industrial Pharmacists of the FIP, Dissolution Tech. 1997; 4: 5-14.

Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutics drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res., 1995; 12: 413–420.

Guidance for industry, “Waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on a biopharmaceutics classification system,” CDER/FDA; August 2000.

Rules and Guidance for Pharmaceutical Manufacturers and Distributors, part 4, Guide to Good Manufacturing Practice for Medical Products, Chapter 6.7, Documentation;1997.

Rules and Guidance for Pharmaceutical Manufacturers and Distributors, part 4, Guide to Good Manufacturing Practice for Medical Products, Chapter 6.16, Testing; 1997.

Code of Federal Regulations, Title 21, Food and Drugs, Part 11, Electronic Records, Electronic Signatures, Final Rule, Fed Reg, 62(54):13429-13466




DOI: http://dx.doi.org/10.7439/ijapa.v7i1.4082

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 International Journal of Advances in Pharmaceutical Analysis